Vertex Pharmaceuticals Incorporated (VX1.DE)
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.
431.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+8.6%
The outlook
Vertex Pharmaceuticals Incorporated currently reads as bullish based on above its 50- & 200-day averages, 78% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range78% of the way from its 52-week low to high
Market cap
$109.39B
52-wk high
464.00
52-wk low
312.65
50-day avg
407.97
200-day avg
390.74
Trailing P/E
29.2